Loading…
Afya Limited is projected to rise to $18.15 by 2027, a +32% move from its current price of $13.75. AFYA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $13.56 | $13.76 | $13.95 | +0.05% |
| May 30 | $13.49 | $13.76 | $14.04 | +0.10% |
| May 31 | $13.43 | $13.77 | $14.12 | +0.15% |
| Jun 1 | $13.39 | $13.78 | $14.18 | +0.20% |
| Jun 2 | $13.35 | $13.78 | $14.23 | +0.25% |
| Jun 3 | $13.32 | $13.79 | $14.28 | +0.30% |
| Jun 4 | $13.29 | $13.80 | $14.33 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.29 | $13.80 | $14.33 | +0.35% |
| Week 2 | $13.13 | $13.85 | $14.61 | +0.71% |
| Week 3 | $13.02 | $13.90 | $14.84 | +1.07% |
| Week 4 | $12.93 | $13.95 | $15.04 | +1.42% |
| Week 5 | $12.86 | $14.00 | $15.23 | +1.78% |
| Week 6 | $12.80 | $14.04 | $15.40 | +2.14% |
| Week 7 | $12.76 | $14.09 | $15.57 | +2.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Afya Limited operates as a medical education group in Brazil, organized into three segments: Undergraduate, Continuing Education, and Medical Practice Solutions.
The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy.
The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.
Afya Limited is a medical education company with a current price of $14.00 and a market cap of $1.25B. It ranks 2368 by market cap.
The 30-day technical picture shows near-term support around $13.81 and resistance near $15.86, with a 30-day range from $12.73 to $15.39.
Forecasts place a gradual rally after 2026, with the 2026 average of $14.00 (min $13.16, max $19.38) and bullish momentum thereafter, as the average rises to $23.16 by 2030 and to $94.88 by 2050. Estimated ROIs reach 65.4% by 2030, 305.9% by 2040, and 577.7% by 2050.
A major floor 10.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 15.3% above — a clean break opens room to run.
A major ceiling 20.5% above — clearing it would confirm fresh momentum.
Key AFYA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AFYA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.02 | Sell | $13.96 | Sell |
| MA 10 | $14.03 | Sell | $14.02 | Sell |
| MA 20 | $14.04 | Sell | $14.15 | Sell |
| MA 50 | $14.63 | Sell | $14.38 | Sell |
| MA 100 | $14.52 | Sell | $14.54 | Sell |
| MA 200 | $14.75 | Sell | $14.92 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.68 | Neutral |
| Stoch RSI (14) | 9.18 | Buy |
| CCI (20) | -155.56 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -1.29 | Sell |
| Bollinger %B (20,2) | 0.03 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.20 | Sell |
| Awesome (5,34) | -0.48 | Sell |
| Ultimate (7,14,28) | 39.83 | Neutral |
| Momentum (10) | -0.44 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 13.95 | Sell |
| ADX (14) | 15.25 | Neutral |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 40.
The asset trades near the key moving averages, with SMA50 at $14.63 and SMA200 at $14.75. The 30-day range runs from $12.73 to $15.39, with support at $13.81 and resistance at $15.86.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.16 | $13.75 | $19.11 | 0% | Neutral | |
| $14.83 | $18.15 | $23.26 | +32% | Bullish | |
| $17.57 | $21.90 | $28.79 | +59% | Bullish | |
| $17.75 | $22.45 | $30.14 | +63% | Bullish | |
| $17.94 | $23.00 | $31.41 | +67% | Bullish | |
| $19.65 | $25.50 | $35.38 | +85% | Bullish | |
| $20.70 | $27.17 | $38.22 | +98% | Bullish | |
| $24.45 | $32.42 | $46.19 | +136% | Bullish | |
| $27.32 | $36.58 | $52.73 | +166% | Bullish | |
| $27.85 | $37.64 | $54.86 | +174% | Bullish | |
| $40.55 | $57.16 | $87.28 | +316% | Bullish | |
| $63.82 | $96.46 | $157.83 | +602% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.16 | $13.75 | $16.06 | +0.00% |
| June 2026 | $11.83 | $13.80 | $16.41 | +0.35% |
| July 2026 | $12.27 | $14.40 | $17.28 | +4.35% |
| August 2026 | $12.52 | $14.75 | $17.84 | +2.45% |
| September 2026 | $12.38 | $14.64 | $17.81 | -0.73% |
| October 2026 | $12.55 | $14.89 | $18.21 | +1.69% |
| November 2026 | $12.94 | $15.41 | $18.93 | +3.48% |
| December 2026 | $12.97 | $15.48 | $19.11 | +0.49% |
Click any year to see its month-by-month AFYA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AFYA to range from $13.16 to $19.11 through 2026. The $13.75 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AFYA price prediction for 2027 points to an average of $18.15 (low $14.83, high $23.26) — a potential gain of +32% on today's $13.75. Buyers look set to stay in control over this stretch.
In 2028, AFYA is projected to trade between $17.57 and $28.79, averaging $21.90 — a potential gain of +59% from today's $13.75. That is up +21% on the projected 2027 average. Momentum favours further upside here.
Afya Limited's 2029 outlook centres on $22.45, within a $17.75 to $30.14 range. That is up +3% on the projected 2028 average. That marks a +63% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, AFYA could reach as high as $31.41, with a base case around $23.00 and support toward $17.94 — roughly +67% from $13.75. Momentum favours further upside here.
Expect AFYA to range from $19.65 to $35.38 through 2031. The $25.50 average target implies a +85% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The AFYA price prediction for 2032 points to an average of $27.17 (low $20.70, high $38.22) — a potential gain of +98% on today's $13.75. Momentum favours further upside here.
In 2033, AFYA is projected to trade between $24.45 and $46.19, averaging $32.42 — a potential gain of +136% from today's $13.75. That is up +19% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Afya Limited's 2034 outlook centres on $36.58, within a $27.32 to $52.73 range. That is up +13% on the projected 2033 average. That marks a +166% change versus current levels. Momentum favours further upside here.
By 2035, AFYA could reach as high as $54.86, with a base case around $37.64 and support toward $27.85 — roughly +174% from $13.75. Buyers look set to stay in control over this stretch.
Expect AFYA to range from $40.55 to $87.28 through 2040. The $57.16 average target implies a +316% move from current prices. That is up +52% on the projected 2035 average. Momentum favours further upside here.
The AFYA price prediction for 2050 points to an average of $96.46 (low $63.82, high $157.83) — a potential gain of +602% on today's $13.75. Buyers look set to stay in control over this stretch.
Investing $1,000 in AFYA today (≈ 72.727273 AFYA) could be worth
$7,015.12
+$6,015.12 (+602%) by 2050 · US Dollar
Based on the average projected AFYA price of $96.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AFYAwould be worth at today's price.
$1,000 invested in AFYA on May 27, 2025 (≈ 54.466229 AFYA) would be worth
$748.91
-$251.09 (-25.1%) today · 0.75× · US Dollar
Based on a AFYA entry price of $18.36 vs. today's $13.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.22 | $966.95 | -3.3% |
| 1 month ago | $13.91 | $988.5 | -1.2% |
| 3 months ago | $13.55 | $1,014.76 | +1.5% |
| 6 months ago | $15.14 | $908.19 | -9.2% |
| 1 year ago | $18.36 | $748.91 | -25.1% |
| All time (5.0y) ago | $23.56 | $583.62 | -41.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AFYA forecast.
Our base-case forecast reaches $28.00 around 2033.
Implied market cap at $28.00: $1.41B
The multi-year forecast is bullish from 2027 onward, with the outlook improving steadily through 2050. These are estimates, not guarantees; actual results may differ due to market conditions.
In 2030 the average price is $23.16 with a return on investment of 65.4%.
In 2040 the average price is $56.83 with ROI of 305.9%.
In 2050 the average price is $94.88 with ROI of 577.7%.
Tap a question to reveal the answer.
Avg price $23.16; min $18.06; max $31.64; ROI 65.4%; sentiment BULLISH.
Forecasts show a bullish trajectory from 2027 onward, with rising averages and ROIs, including 2027 avg $18.46 and ROI 31.9%, 2031 avg $25.72 and ROI 83.7%, and 2050 avg $94.88 and ROI 577.7%.
Yes. The 2030 max is $31.64, and the 2033 max is $46.22, indicating it can surpass $30 in some years.
Current price $14.00; Market cap $1.25B.
Avg price $56.83; ROI 305.9%; sentiment BULLISH.
Afya Limited Community Discussion
0Share your Afya Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.